Company intelligence / Profile preview

BioNews

Pensacola, Florida, USAbionews.com ↗

Ownership: Private
Employees: ~133
Development stage: Other

Overview

BioNews is an active digital health solutions company focused on empowering rare disease communities by providing trusted news, information resources, patient stories, and peer-to-peer connections. It operates more than 60 disease-specific online publications and social platforms to connect patients with the latest research developments and support networks. The company also partners with biotech/pharma for patient engagement initiatives but does not itself conduct clinical trials or drug development.

Therapeutic areas: Rare DiseasesPulmonologyNeurology
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Works with pharmaceutical/biotech companies for patient engagement campaignsAdvisory board members from PfizerAdvisory board members from UCB

Beyond the preview

Go deeper on BioNews.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioNews.

Explore the full profile